Physician

Donald B Wender, M.D.

According to 2025 Medicare claims, Donald Wender, M.D. (NPI: 1861463275) practices hematology/oncology in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is SIOUXLAND REGIONAL CANCER CENTER (NPI: 1114904604; TIN: 421411233) and primary practice location at 51101-1733. Wender is affiliated with the Prairie Vista Care Organization (ACO ID: A3578), Bryan Health Connect ACO, LLC (ACO ID: A4573), Avera Prairie View ACO (ACO ID: A4692), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Wender's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,459 traditional Medicare patients, billed 264,002 HCPCS/CPT codes, and received $6,575,474 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,187 prescription claims across 411 beneficiaries totaling $6,439,369 in drug costs, led by Revlimid (Lenalidomide). DME data shows 13 claims. Open Payments data shows 204 records totaling $80,598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,245,459 to $6,575,474. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,960,663 to $6,439,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,247	140,716	$2,245,459
2016	1,101	90,183	$1,774,168
2017	1,050	100,981	$1,587,348
2018	1,183	123,273	$2,567,585
2019	1,135	119,252	$2,418,302
2020	987	145,195	$2,732,374
2021	1,044	136,333	$2,634,511
2022	1,051	168,950	$3,430,453
2023	1,026	214,818	$4,527,525
2024	1,459	264,002	$6,575,474

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	335	2,016	$1,960,663
2016	333	1,882	$2,260,365
2017	303	1,707	$2,062,290
2018	355	1,929	$1,969,963
2019	297	1,605	$2,156,709
2020	301	1,748	$2,647,986
2021	296	1,736	$3,238,739
2022	334	2,053	$6,757,037
2023	357	2,127	$7,075,160
2024	411	2,187	$6,439,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	151	$60,483
2016	N/R	47	$20,533
2017	13	41	$19,867
2018	12	28	$9,355
2019	N/R	30	$4,781
2020	N/R	50	$3,677
2021	N/R	87	$4,958
2022	N/R	86	$2,176
2023	N/R	75	$19,811
2024	11	13	$226

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	455	894	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	786	1,484	$12
80053	Blood test, comprehensive group of blood chemicals	830	1,973	$10
36415	Insertion of needle into vein for collection of blood sample	793	1,621	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	897	2,249	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	66	1,779	$1,167,184
Calquence	Acalabrutinib Maleate	59	1,770	$732,040
Imbruvica	Ibrutinib	40	1,126	$611,978
Lenalidomide	Lenalidomide	43	1,176	$554,528
Kisqali	Ribociclib Succinate	24	672	$380,335

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	11	13	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$2,979	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	44	$77,619	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Donald B. Wender, M.D.?

Tedicare shows public-source Medicare data for Donald B. Wender, M.D. (NPI 1861463275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Donald B. Wender, M.D. have ACO affiliation data?

Donald B. Wender, M.D. is shown with ACO affiliation data for Prairie Vista Care Organization (MSSP, ACO ID A3578), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Avera Prairie View ACO (MSSP, ACO ID A4692), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Donald B. Wender, M.D.?

Donald B. Wender, M.D. is linked to SIOUXLAND REGIONAL CANCER CENTER (billing NPI 1114904604) in the available physician profile data.

Does Donald B. Wender, M.D. have Open Payments data?

Donald B. Wender, M.D. has 204 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.